Literature DB >> 12023947

Hyper-reactivity of diacylglycerol kinase is involved in the dysfunction of aortic smooth muscle contractility in streptozotocin-induced diabetic rats.

Koji Nobe1, Yasushi Sakai, Yoshiaki Maruyama, Kazutaka Momose.   

Abstract

1. Dysfunction of vascular contraction in diabetes has been reported; however, the mechanisms are poorly understood. In this study, calcium sensitization involving increases in contraction in streptozotocin-induced diabetic rat aorta was detected. We hypothesize that an alteration in the intracellular signalling system plays a role in the dysfunction of vascular contractility in diabetes. Therefore, diacylglycerol (DG) kinase as a key enzyme of phosphatidylinositol (PI) turnover was investigated. 2. Treatment with norepinephrine (NE) caused time- and dose-dependent activation of DG kinase in control rats. This activation required simultaneous increases in intracellular calcium concentration ([Ca2+]i) and protein kinase C (PKC) activation. I3. n diabetic rats, hyper-reactivity of DG kinase involving inactivation in the resting state and over-activation in NE stimulation was observed. During hyper-reactivity, [Ca2+]i dependency of DG kinase was enhanced. Treatment with 50 mM KCl induced significant escalation in activity; moreover, basal activation of PKC was detected only in diabetes. These results suggested that PKC had been activated in the resting state. In contrast, these conditions were insufficient for DG kinase activation due to the absence of [Ca2+]i elevation. 4. During NE-stimulation, PKC activation was maintained and [Ca2+]i increased. Therefore, DG kinase was activated and an elevation in calcium dependency enhanced this activation. 5. The present study suggested that DG kinase hyper-reactivity in diabetes involved both an increase in [Ca2+]i and basal activation of PKC. This phenomenon may be associated with increased vascular contraction in diabetes mediated by acceleration of PI-turnover.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12023947      PMCID: PMC1573360          DOI: 10.1038/sj.bjp.0704722

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  23 in total

1.  Enhanced arterial contractility to noradrenaline in diabetic rats is associated with increased phosphoinositide metabolism.

Authors:  W Abebe; K M MacLeod
Journal:  Can J Physiol Pharmacol       Date:  1991-03       Impact factor: 2.273

2.  Effect of diabetes on fast response to norepinephrine in rat aorta.

Authors:  G J Rinaldi; H E Cingolani
Journal:  Diabetes       Date:  1992-01       Impact factor: 9.461

3.  d-Alpha-tocopherol prevents the hyperglycemia induced activation of diacylglycerol (DAG)-protein kinase C (PKC) pathway in vascular smooth muscle cell by an increase of DAG kinase activity.

Authors:  I K Lee; D Koya; H Ishi; H Kanoh; G L King
Journal:  Diabetes Res Clin Pract       Date:  1999-09       Impact factor: 5.602

4.  Streptozotocin treatment of streptozotocin-induced islet cell adenomas in rats.

Authors:  N Rakieten; B S Gordon; A Beaty; R W Bates; P S Schein; F G Standaert
Journal:  Proc Soc Exp Biol Med       Date:  1976-03

5.  Effect of insulin treatment on smooth muscle contractility and endothelium-dependent relaxation in rat aortae from established STZ-induced diabetes.

Authors:  T Kobayashi; K Kamata
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

6.  Enhanced contractile responses of arteries from diabetic rats to alpha 1-adrenoceptor stimulation in the absence and presence of extracellular calcium.

Authors:  W Abebe; K H Harris; K M MacLeod
Journal:  J Cardiovasc Pharmacol       Date:  1990-08       Impact factor: 3.105

7.  Effect of diacylglycerol kinase inhibitor, R59022 on cytosolic free calcium level and force development in guinea pig taenia coli.

Authors:  K Nobe; H Ohata; K Momose
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1993-09

8.  Neomycin inhibition of hormone-stimulated smooth muscle contractions in myometrial tissue.

Authors:  M Phillippe
Journal:  Biochem Biophys Res Commun       Date:  1994-11-30       Impact factor: 3.575

9.  Evidence for attenuation of myo-inositol uptake, phosphoinositide turnover and inositol phosphate production in aortic vasculature of rats during pregnancy.

Authors:  K P Conrad; S A Barrera; P A Friedman; V M Schmidt
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

10.  Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation.

Authors:  T Inoguchi; R Battan; E Handler; J R Sportsman; W Heath; G L King
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

View more
  8 in total

1.  Novel diacylglycerol kinase inhibitor selectively suppressed an U46619-induced enhancement of mouse portal vein contraction under high glucose conditions.

Authors:  Koji Nobe; Mari Miyatake; Hiromi Nobe; Yasushi Sakai; Junko Takashima; Kazutaka Momose
Journal:  Br J Pharmacol       Date:  2004-08-02       Impact factor: 8.739

2.  Elevated Glucose Levels Promote Contractile and Cytoskeletal Gene Expression in Vascular Smooth Muscle via Rho/Protein Kinase C and Actin Polymerization.

Authors:  Tran Thi Hien; Karolina M Turczyńska; Diana Dahan; Mari Ekman; Mario Grossi; Johan Sjögren; Johan Nilsson; Thomas Braun; Thomas Boettger; Eliana Garcia-Vaz; Karin Stenkula; Karl Swärd; Maria F Gomez; Sebastian Albinsson
Journal:  J Biol Chem       Date:  2015-12-18       Impact factor: 5.157

3.  R59949, a diacylglycerol kinase inhibitor, inhibits inducible nitric oxide production through decreasing transplasmalemmal L-arginine uptake in vascular smooth muscle cells.

Authors:  Tomoko Shimomura; Tomoyuki Nakano; Kaoru Goto; Ichiro Wakabayashi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-12-01       Impact factor: 3.000

4.  Diacylglycerol Kinase Inhibition and Vascular Function.

Authors:  Hyehun Choi; Kyan J Allahdadi; Rita C A Tostes; R Clinton Webb
Journal:  Curr Enzym Inhib       Date:  2009

5.  Toll-like receptor 2 mediates vascular contraction and activates RhoA signaling in vascular smooth muscle cells from STZ-induced type 1 diabetic rats.

Authors:  Luke Schmidt; Maria Alicia Carrillo-Sepulveda
Journal:  Pflugers Arch       Date:  2015-01-21       Impact factor: 3.657

6.  Role of calcium-independent phospholipase A2beta in high glucose-induced activation of RhoA, Rho kinase, and CPI-17 in cultured vascular smooth muscle cells and vascular smooth muscle hypercontractility in diabetic animals.

Authors:  Zhongwen Xie; Ming C Gong; Wen Su; Dongping Xie; John Turk; Zhenheng Guo
Journal:  J Biol Chem       Date:  2010-01-19       Impact factor: 5.157

7.  Oxidative stress and COX cause hyper-responsiveness in vascular smooth muscle of the femoral artery from diabetic rats.

Authors:  Y Shi; P M Vanhoutte
Journal:  Br J Pharmacol       Date:  2008-04-14       Impact factor: 8.739

8.  The diabetes-induced functional and distributional changes of the alpha 1-adrenoceptor of the abdominal aorta and distal mesenteric artery from streptozotocin-induced diabetic rats.

Authors:  Jong-Hwan Lee; Jae-Hyon Bahk; Sang-Hyun Park; Jin Huh
Journal:  Korean J Anesthesiol       Date:  2011-04-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.